组织学确诊子宫内膜异位症女性双侧输卵管卵巢切除术后卵巢癌发生率
荷兰全国病理数据库回顾性队列研究,纳入1990至2015年间行双侧输卵管卵巢切除术的组织学确诊子宫内膜异位症女性7984例,与未行该术的子宫内膜异位症女性42633例及良性皮肤痣女性132535例对照。术后(额外)卵巢癌发生率低于两个对照组,年龄调整IRR分别为0.34和0.38。
要点
- 双侧输卵管卵巢切除术后(额外)卵巢癌9例(0.1%),低于子宫内膜异位症对照组的170例(0.4%)和痣对照组的444例(0.3%)。
- 与子宫内膜异位症对照组相比年龄调整IRR 0.34(95%CI 0.15-0.76),与痣对照组相比年龄调整IRR 0.38(95%CI 0.17-0.85)。
- 与子宫内膜异位症对照组相比需治疗人数为351(95%CI 272-591)。
核心结论
- 全国性研究显示,组织学确诊子宫内膜异位症女性行双侧输卵管卵巢切除术后(额外)卵巢癌发生率降至低于背景人群风险。
- 与未行双侧输卵管卵巢切除术的组织学确诊子宫内膜异位症女性相比,卵巢癌发生率显著降低。
- 作者认为子宫内膜异位症手术未来可能成为具有卵巢癌高风险特征子宫内膜异位症女性的预防策略。
研究设计与样本
- 回顾性全国性队列研究,数据来自荷兰病理数据库。
- 纳入1990至2015年间行双侧输卵管卵巢切除术的组织学确诊子宫内膜异位症女性7984例。
- 对照队列包括未行双侧输卵管卵巢切除术的组织学确诊子宫内膜异位症女性42633例和良性皮肤痣女性132535例。
主要发现
- 双侧输卵管卵巢切除术队列中检出(额外)卵巢癌9例(0.1%)。
- 子宫内膜异位症对照队列检出卵巢癌170例(0.4%),痣对照队列检出卵巢癌444例(0.3%)。
- 双侧输卵管卵巢切除术队列与子宫内膜异位症对照队列比较,年龄调整IRR为0.34(95%CI 0.15-0.76)。
- 双侧输卵管卵巢切除术队列与痣对照队列比较,年龄调整IRR为0.38(95%CI 0.17-0.85)。
- 与子宫内膜异位症对照队列比较,需治疗人数为351(95%CI 272-591)。
关键数值与推荐
- 主要结局为(额外)卵巢癌的组织学诊断数量。
- 估计(额外)卵巢癌的发生率比值(IRR),并计算需治疗人数。
临床怎么用
- 原文结论未据此给出临床推荐。
- 作者认为子宫内膜异位症手术未来可能成为具有卵巢癌高风险特征子宫内膜异位症女性的预防策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the incidence of ovarian cancer in women with histologically proven endometriosis after bilateral salpingo-oophorectomy (BSO). DESIGN: Retrospective nationwide cohort study. SETTING: Dutch pathology database. PATIENT(S): Women with histologically proven endometriosis who had undergone BSO between 1990 and 2015 (n = 7,984). This study consists of 2 control cohorts: women with histologically proven endometriosis without BSO (n = 42,633) and women with a benign dermal nevus (n = 132,535). INTERVENTION(S): Observational study. MAIN OUTCOME MEASURE(S): Number of histologic diagnoses of (extra-)ovarian cancers. Incidence rate ratios (IRR) were estimated for (extra-)ovarian cancer. The number needed to treat was calculated. RESULT(S): We identified 9 (0.1%) (extra-)ovarian cancers in the BSO cohort and 170 (0.4%) and 444 (0.3%) ovarian cancers in the endometriosis and nevus control cohorts, respectively. We found an age-adjusted IRR of 0.34 (95% confidence interval [CI], 0.15-0.76) when the BSO cohort was compared with the endometriosis cohort. Comparing the BSO cohort with the nevus control cohort resulted in an age-adjusted IRR of 0.38 (95% CI, 0.17-0.85). The number needed to treat when the BSO cohort was compared with the endometriosis control cohort was 351 (95% CI, 272-591). CONCLUSION(S): In this nationwide study, we found that the (extra-)ovarian cancer incidence in women with histologically proven endometriosis decreased to less than the background population risk after BSO. Additionally, we found a significant reduction of the incidence of ovarian cancer when compared with women with histologically proven endometriosis without BSO. Endometriosis surgery could in the future be a preventive strategy in women with endometriosis and a high-risk profile for ovarian cancer.
引用
- Hermens M, van Altena AM, Bulten J, et al. Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis. Fertil Steril. 2022. PMID: 35300832. doi:10.1016/j.fertnstert.2022.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。